Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Annals of Hematology|January 14, 2026
Ponatinib for CML patients in routine clinical practice: the PONDEROSA studyThomas Schenk, Christian Fabisch, Thomas Ernst, et al.Oncotarget|March 7, 2018
PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cellsJulia Drube, Thomas Ernst, Markus Pfirrmann, et al.Journal of Cancer Research and Clinical Oncology|December 3, 2019
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN)Annamaria Brioli, Kirsi Manz, Markus Pfirrmann, et al.Leukemia|December 19, 2025
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspectivePhilipp Ernst, Cera Lohse, Michael Lauseker, et al.Leukemia|July 28, 2022
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemiaLioba Schönfeld, Jenny Rinke, Anna Hinze, et al.Leukemia|March 29, 2024
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase RegistryAnnamaria Brioli, Elza Lomaia, Christian Fabisch, et al.Leukemia|February 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phaseMichael Lauseker, Tomasz Sacha, Hana Klamova, et al.Pageof 1